Using established biomarkers for breast cancer which are currently available in clinical practice, we first developed a predictive model including HSP90AA1, which can be used to calculate breast cancer risk for breast disease and risk of distant metastasis in breast cancer. Here, HSP90AA1 is linked to breast carcinoma.